Table 1 Characteristics of the study subjects and comparison of characteristics between children in the Ortholiposis and Dyslipidemia

Age, yr

6.7 ± 2.6

6.7 ± 2.5

7.0 ± 2.9

0.001

Boys [n (%)]

3174 (64.5)

2673 (65.7)

501 (58.5)

 < 0.001

BMI z score

0.36 ± 1.17

0.32 ± 1.17

0.56 ± 1.13

 < 0.001

SUA, mg/dL

4.27 ± 1.01

4.22 ± 0.97

4.51 ± 1.15

 < 0.001

Hyperuricemia defined as ≥ 5.5 mg/dL (%)

542 (11.0)

390 (9.6)

152 (17.8)

 < 0.001

Hyperuricemia defined as ≥ 7.0 mg/dL (%)

78 (1.6)

49 (1.2)

29 (3.4)

 < 0.001

FPG, mmol/L

4.44 ± 0.47

4.44 ± 0.47

4.47 ± 0.48

0.091

TC, mmol/L

3.85 ± 0.67

3.81 ± 0.56

4.04 ± 1.02

 < 0.001

TG, mmol/L

0.87 ± 0.52

0.75 ± 0.25

1.46 ± 0.91

 < 0.001

HDL-C, mmol/L

1.40 ± 0.30

1.45 ± 0.26

1.14 ± 0.33

 < 0.001

Non-HDL-C, mmol/L

2.45 ± 0.62

2.35 ± 0.51

2.90 ± 0.85

 < 0.001

LDL-C, mmol/L

2.16 ± 0.57

2.11 ± 0.48

2.44 ± 0.83

 < 0.001

ALT, U/L

13.04 ± 4.25

12.79 ± 4.02

14.24 ± 5.06

 < 0.001

AST, U/L

23.54 ± 5.08

23.64 ± 4.96

23.06 ± 5.60

0.005

GGT, U/L

10.65 ± 3.68

10.36 ± 3.28

12.05 ± 4.94

 < 0.001

ALP, U/L

241.41 ± 60.84

240.48 ± 59.74

245.82 ± 65.66

0.028

Serum urea, μmol/L

4.58 ± 0.97

4.59 ± 0.97

4.52 ± 0.99

0.058

Serum Cr, μmol/L

38.21 ± 8.02

38.17 ± 7.86

38.39 ± 8.74

0.488